img

Drug Response

Marker Discovery for Drug Responders/Non-Responders

  • icon
    Basgenbio predicts drug responders and non-responders
    by developing algorithms for drug effectiveness, applicable to
    personalized medicine development.

    Framework

    Identifying biomarkers that classify drug responders and non-responders is an essential technology for developing personalized treatments.

    img

    Case of Drug Response Biomarker Discovery (Antidepressants)

    * RCT : Randomized Clinical Trial

    Response Marker Interaction GWAS
    arrow
    img
    Comparative Analysis of Antidepressant Responders vs.
    Non-Responders

    Exploration of Antidepressant Resistance-Related Markers

    Resistant, Non-Resistant Interaction Filtering

    Final set of 27 markers established.

    Classifier Performance
    img
    Comparison and Performance Analysis of Resistance Group Marker Gene Scores

    Resistant Group Prediction Performance AUC: 0.63

    Credit

    Project Manager
    Jungoh Kim, Ph.D.
    Project Assistant
    Hyunjoon Lim
    Project Leader
    Sanghyuck Yoon
    Data Analyst
    Jiwon Lim, Jihi Cha